Cargando…

Understanding the Representative Gut Microbiota Dysbiosis in Metformin-Treated Type 2 Diabetes Patients Using Genome-Scale Metabolic Modeling

Dysbiosis in the gut microbiome composition may be promoted by therapeutic drugs such as metformin, the world’s most prescribed antidiabetic drug. Under metformin treatment, disturbances of the intestinal microbes lead to increased abundance of Escherichia spp., Akkermansia muciniphila, Subdoligranu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosario, Dorines, Benfeitas, Rui, Bidkhori, Gholamreza, Zhang, Cheng, Uhlen, Mathias, Shoaie, Saeed, Mardinoglu, Adil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026676/ https://www.ncbi.nlm.nih.gov/pubmed/29988585 http://dx.doi.org/10.3389/fphys.2018.00775

Ejemplares similares

Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment
por: Ezzamouri, Bouchra, et al.
Publicado: (2023)

ESS: A Tool for Genome-Scale Quantification of Essentiality Score for Reaction/Genes in Constraint-Based Modeling
por: Zhang, Cheng, et al.
Publicado: (2018)

Systems Biology Approaches to Understand the Host–Microbiome Interactions in Neurodegenerative Diseases
por: Rosario, Dorines, et al.
Publicado: (2020)

Metabolic Network-Based Identification and Prioritization of Anticancer Targets Based on Expression Data in Hepatocellular Carcinoma
por: Bidkhori, Gholamreza, et al.
Publicado: (2018)

Genome-scale metabolic modelling of the human gut microbiome reveals changes in the glyoxylate and dicarboxylate metabolism in metabolic disorders
por: Proffitt, Ceri, et al.
Publicado: (2022)

Disease, Drugs and Dysbiosis: Understanding Microbial Signatures in Metabolic Disease and Medical Interventions
por: Proffitt, Ceri, et al.
Publicado: (2020)

New Challenges to Study Heterogeneity in Cancer Redox Metabolism
por: Benfeitas, Rui, et al.
Publicado: (2017)

Understanding the interactions between bacteria in the human gut through metabolic modeling
por: Shoaie, Saeed, et al.
Publicado: (2013)

Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling
por: Ghaffari, Pouyan, et al.
Publicado: (2015)

Systems biology perspective for studying the gut microbiota in human physiology and liver diseases
por: Altay, Ozlem, et al.
Publicado: (2019)

Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis
por: Benfeitas, Rui, et al.
Publicado: (2018)

TCSBN: a database of tissue and cancer specific biological networks
por: Lee, Sunjae, et al.
Publicado: (2018)

Acute kidney injury leading to CKD is associated with a persistence of metabolic dysfunction and hypertriglyceridemia
por: Harzandi, Azadeh, et al.
Publicado: (2021)

Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease
por: Sultan, Salma, et al.
Publicado: (2021)

The gut microbiota modulates host amino acid and glutathione metabolism in mice
por: Mardinoglu, Adil, et al.
Publicado: (2015)

Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning
por: Turanli, Beste, et al.
Publicado: (2019)

Drug Repositioning for Effective Prostate Cancer Treatment
por: Turanli, Beste, et al.
Publicado: (2018)

Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer
por: Turanli, Beste, et al.
Publicado: (2019)

Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme
por: Kaynar, Ali, et al.
Publicado: (2021)

Applications of Genome-Wide Screening and Systems Biology Approaches in Drug Repositioning
por: Mohammadi, Elyas, et al.
Publicado: (2020)

Associations between dysbiosis gut microbiota and changes of neurotransmitters and short-chain fatty acids in valproic acid model rats
por: Zhong, Jiu-Gen, et al.
Publicado: (2023)

Sleep Deprivation and Gut Microbiota Dysbiosis: Current Understandings and Implications
por: Sun, Jingyi, et al.
Publicado: (2023)

Genome-Scale Metabolic Modeling of Glioblastoma Reveals Promising Targets for Drug Development
por: Larsson, Ida, et al.
Publicado: (2020)

Revealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis
por: Bayraktar, Abdulahad, et al.
Publicado: (2021)

Systems Analysis Reveals Ageing-Related Perturbations in Retinoids and Sex Hormones in Alzheimer’s and Parkinson’s Diseases
por: Lam, Simon, et al.
Publicado: (2021)

Dysbiosis of the gut microbiota in disease
por: Carding, Simon, et al.
Publicado: (2015)

Editorial: The Impact of Systems Medicine on Human Health and Disease
por: Mardinoglu, Adil, et al.
Publicado: (2016)

Systematic diet composition swap in a mouse genome-scale metabolic model reveals determinants of obesogenic diet metabolism in liver cancer
por: Clasen, Frederick, et al.
Publicado: (2023)

A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma
por: Yuan, Meng, et al.
Publicado: (2022)

Metformin modulates the gut microbiome in broiler breeder hens
por: Van Syoc, Emily, et al.
Publicado: (2022)

Tamoxifen-Induced Apoptosis of MCF-7 Cells via GPR30/PI3K/MAPKs Interactions: Verification by ODE Modeling and RNA Sequencing
por: Rouhimoghadam, Milad, et al.
Publicado: (2018)

Personalized Cardiovascular Disease Prediction and Treatment—A Review of Existing Strategies and Novel Systems Medicine Tools
por: Björnson, Elias, et al.
Publicado: (2016)

Cancer Metabolism: A Modeling Perspective
por: Ghaffari, Pouyan, et al.
Publicado: (2015)

Elucidating the interactions between the human gut microbiota and its host through metabolic modeling
por: Shoaie, Saeed, et al.
Publicado: (2014)

Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis
por: Zeybel, Mujdat, et al.
Publicado: (2022)

Human Gut Microbiota: Dysbiosis and Manipulation
por: Shen, Dongqian, et al.
Publicado: (2012)

Gut Microbiota Dysbiosis in Functional Dyspepsia
por: Tziatzios, Georgios, et al.
Publicado: (2020)

Problems with the concept of gut microbiota dysbiosis
por: Brüssow, Harald
Publicado: (2019)

Development of the gut microbiota and dysbiosis in children
por: AKAGAWA, Shohei, et al.
Publicado: (2020)

Association of metformin administration with gut microbiome dysbiosis in healthy volunteers
por: Elbere, Ilze, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q65lhiu25h6v1h99ptg76sdsis